| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.51 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |